Drug intelligence / Profile preview

4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile is a synthetic small molecule belonging to the indole class of organic compounds, characterized by an indole moiety with a substituted hydroxypropyl and tert-butylamino side chain. It has a molecular formula of C16H21N3O2 and a molecular weight of approximately 287.36 g/mol[1][3]. The compound is listed as experimental and does not have any approved medical indications or known clinical use as of now[3]. Its mechanism of action, biological targets, pharmacological activity, and therapeutic potential are not described in publicly available drug databases. There are no records indicating it has reached clinical trials or been developed for any disease area[1][3].

Other names
4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3H-indole-2-carbonitrile4-{(2S)-2-Hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy}-3H-indol-2-carbonitril

Beyond the preview

Go deeper on 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call